Most Recent and Selected from a total of over 100 peer-reviewed publications
Savoia E, Testa MA, Biddinger PD, Cadigan RO, Koh H, Campbell P, Stoto MA. Assessing public health capabilities during emergency preparedness tabletop exercises: reliability and validity of a measurement tool. Public Health Rep. 2009 Jan-Feb;124(1):138-48.
Testa M and Simonson D. The Use of Questionnaires and Surveys. In: Robertson D and Williams G Clinical and Translational Sciences. London: Elsevier. 2009 Chapter 9, pp 137-153.
Smitten AL, Choi HK Hochberg MC, Suissa A, Simon TA, Testa MA, Chan KA. The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol. 2008 Mar;35(3):387-93
Reynolds NR, Testa MA, Su M, Chesney MA, Neidig JL, Frank I, Smith S, Ickovics J, Robbins GK; for the AIDS Clinical Trials Group 731 and 384 Teams. Telephone support to improve antiretroviral medication adherence: A multisite, randomized controlled trial. J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):62-8.
Smitten AL, Choi HK Hochberg MC, Suissa A, Simon TA, Testa MA, Chan KA. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum. 2007 Dec 15;57(8):1431-8.
Marc LG, Testa MA, Walker AM, Robbins GK, Shafer RW, Anderson NB, Berkman LF; ACTG Data Analysis Concept Sheet Study Team. Educational attainment and response to HAART during initial therapy for HIV-1 infection. J Psychosom Res. 2007 Aug;63(2):207-16.
Testa MA, Simonson DC. Satisfaction and quality of life with premeal inhaled versus injected insulin in adolescents and adults with type 1 diabetes. Diabetes Care. 2007;30: 1399 – 1405.
Dorn BC, Savoia E, Testa MA, Stoto MA, Marcus LJ. Development of a survey instrument to measure connectivity to evaluate national public health preparedness and response performance. Public Health Rep. 2007 May-Jun;122(3):329-38.
Meaney PA, Nadkarni VM, Cook EF, Testa M, Helfaer M, Kaye W, Larkin GL, Berg RA;American Heart Association National Registry of Cardiopulmonary Resuscitation Investigators. Higher survival rates among younger patients after pediatric intensive care unit cardiac arrests. Pediatrics. 2006;118:2424-33.
Straus DJ, Testa MA, Sarokhan BJ, Czuczman MS, Tulpule A, Turner RT, Riggs SA.Treatment of Mild Anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies, Cancer, 2006;107:1909-1917.
Beal AC, Chou SC, Palmer RH, Testa MA, Newman C, Ezhuthachan S. The changing face of race: risk factors for neonatal hyperbilirubinemia. Pediatrics. 2006 May;117(5):1618-25.
Fletcher CV, Testa MA, Brundage RC, Chesney MA, Haubrich R, Acosta EP, Martinez A, Jiang H, Gulick RM. Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359. J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):301-6.
Max S, Testa MA. Latent Variable Growth Model Approach to Analyzing Multiple HealthOutcomes from Clinical Trials, Book Chapter, 2005.
Reynolds NR, Testa MA, Marc L, Chesney MA Neidig JL, Smith SR, Vella S, Robbins GK for the Protocol Teams of ACTG 384, ACTG 731 and A5031s. Factors influencing medication adherence beliefs and self-efficacy in persons naïve to antiretroviral therapy: a multi-center, cross-sectional study. AIDS and Behavior, 2004; 8:141-150.
Chou SC, Heather Palmer R, Ezhuthachan S, Newman C, Pradell-Boyd, B, Maisels J, Testa MA . Management of Hyperbilirubinemia in Newborns: Measuring Performance by Using a Benchmarking Model. Pediatrics 2004; 112: 1264-1273.
Yang CC, Jick SS, Testa MA . Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation. British Journal of Clinical Pharmacology 2003; 55, 288-298.
Miles SA, Testa M , Huang J, Wade M, Carden J, Scadden DT. Lack of antitumor activity and intolerance of interleukin-4 in patients with advanced HIV disease and Kaposi’s sarcoma. J Interferon Cytokine Res. 2002 ;22:1143-8.
Bacon CG, Giovannucci E, Testa M, Kawachi I. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol 2001;166(5):1804-10.
Testa MA. Methods and applications of quality-of-life measurement during antihypertensive therapy. Curr Hypertens Rep. 2000; (6):530-7.
Testa MA. Interpretation of quality of life outcomes: Issues that affect magnitude and meaning. Medical Care 2000; 38 [suppl II]:II-166-II-174.
Testa MA. Quality-of-life assessment in diabetes research: Interpreting the magnitude and meaning of treatment effects. Diabetes Spectrum, 2000; 13:36-41.
Testa MA and Lenderking WR. The impact of AIDS-associated wasting on quality of life: Qualitative issues of measurement and evaluation. Journal of Nutrition, 1999;129:282S-289S.
Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: A randomized controlled, double-blind trial. JAMA, 1998; 280:1490-1496.
Testa MA and Simonson DC. Assessing quality-of-life outcomes. N Engl J Med, 1996; 334:835-840.
Testa MA, Nackley JF. Methods for quality-of-life studies. Annu Rev Public Health 1994; 15:535-59.
Testa MA, Anderson RB, Nackley JF and Hollenberg NK: Quality of life and antihypertensive therapy in men: A comparison of captopril with enalapril N Eng J Med 1993; 328:907-13.